433 filings
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
5 Jan 24
Other Events
5:50pm
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Dec 23
Entry into a Material Definitive Agreement
8:25am
8-K/A
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
vubkmvi0
18 Oct 23
Other Events
9:03am
8-K
t6ala hsis67a
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
vlzg3
27 Sep 23
Departure of Directors or Certain Officers
8:38am
8-K
47tpz7dqn8ydxn6 14
18 Sep 23
Other Events
5:26pm
8-K
6u3l2
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
27kklxkzux5wh j2
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
c7cvg
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
8-K
cgijz
13 Mar 23
Other Events
8:02am
8-K
tkle5lrhhuj
22 Feb 23
Ligand Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
d1blko7gvo65amehz2hl
14 Dec 22
Departure of Directors or Certain Officers
4:07pm
8-K
degfn soq9sbbm
5 Dec 22
Departure of Directors or Certain Officers
7:03am
8-K
6lae3husjzou
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
uan0yq kfqeunn
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
8-K
ii8q1tgzm v3jh
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
8-K
4b0ra1ugow9ss
30 Sep 22
Entry into a Material Definitive Agreement
5:13pm